MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 598762 | Name: Tresperimus

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tresperimus induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model.

Chemical Structure

Tresperimus
Tresperimus
CAS#160677-67-8

Theoretical Analysis

MedKoo Cat#: 598762

Name: Tresperimus

CAS#: 160677-67-8

Chemical Formula: C17H37N7O3

Exact Mass: 387.2958

Molecular Weight: 387.52

Elemental Analysis: C, 52.69; H, 9.62; N, 25.30; O, 12.39

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
160677-67-8 (free base) 160678-11-5 (3HCl)
Synonym
Tresperimus; LF-08-0299; LF 08-0299; LF08-0299;
IUPAC/Chemical Name
2-((6-guanidinohexyl)amino)-2-oxoethyl (4-((3-aminopropyl)amino)butyl)carbamate
InChi Key
LVBMFPUTQOHXQE-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H37N7O3/c18-8-7-10-21-9-5-6-13-24-17(26)27-14-15(25)22-11-3-1-2-4-12-23-16(19)20/h21H,1-14,18H2,(H,22,25)(H,24,26)(H4,19,20,23)
SMILES Code
O=C(OCC(NCCCCCCNC(N)=N)=O)NCCCCNCCCN
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 387.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Bousquet E, Camelo S, Leroux les Jardins G, Goldenberg B, Naud MC, Besson-Lescure B, Lebreton L, Annat J, Behar-Cohen F, de Kozak Y. Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 2011 Jul 20;52(8):5414-23. doi: 10.1167/iovs.10-6740. PubMed PMID: 21666239. 2: Simpson D. Tresperimus: a new agent for transplant tolerance induction. Expert Opin Investig Drugs. 2001 Jul;10(7):1381-6. Review. PubMed PMID: 11772258. 3: el Marsafy S, Dutartre P, Gluckman E. Effect of tresperimus on ex vivo expansion of CD34+CD38(-)-enriched cord blood cells. Haematologia (Budap). 2002;32(4):327-36. PubMed PMID: 12803107. 4: Claud P, Artur Y, Guichard JP, Laine R. Metabolism of tresperimus by rat aorta semicarbazide-sensitive amine oxidase (SSAO). Fundam Clin Pharmacol. 2002 Dec;16(6):461-70. PubMed PMID: 12685504. 5: Claud P, Artur Y, Laine R. In vitro metabolism of tresperimus by human vascular semicarbazide-sensitive amine oxidase. Drug Metab Dispos. 2002 Jun;30(6):747-55. PubMed PMID: 12019205. 6: El Marsafy S, Dutartre P, Gluckman E. Effect of tresperimus on in vitro human cord blood CD34+ cell differentiation. Haematologia (Budap). 2001;31(2):139-46. PubMed PMID: 11583025. 7: Claud P, Padovani P, Guichard JP, Artur Y, Lainé R. Involvement of semicarbazide-sensitive amine oxidase in tresperimus metabolism in human and in rat. Drug Metab Dispos. 2001 May;29(5):735-41. PubMed PMID: 11302941. 8: Elices MJ. Tresperimus (Laboratoires Fournier). Curr Opin Investig Drugs. 2001 Mar;2(3):372-4. PubMed PMID: 11575707. 9: Komesli S, Dumas C, Dutartre P. Analysis of in vivo immunosuppressive and in vitro interaction with constitutive heat shock protein 70 activity of LF08-0299 (Tresperimus) and analogues. Int J Immunopharmacol. 1999 May;21(5):349-58. PubMed PMID: 10408631. 10: Annat J, Dutartre P. T cell repertoire expression in murine recipients of bone marrow transplant after LF 08-0299 (Tresperimus) administration. Transpl Immunol. 1998 Dec;6(4):217-24. PubMed PMID: 10342735. 11: Tresperimus. LF 080299. Drugs R D. 1999 Jan;1(1):110-1. PubMed PMID: 10566003. 12: Jacobsohn DA, Vogelsang GB. Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. Drugs. 2002;62(6):879-89. Review. PubMed PMID: 11929336. 13: Simpson D. Drug therapy for acute graft-versus-host disease prophylaxis. J Hematother Stem Cell Res. 2000 Jun;9(3):317-25. Review. PubMed PMID: 10894353. 14: Bruley-Rosset M, Churaqui E, Annat J, Dutartre P. LF 08-0299 protects murine recipients of minor antigen disparate donor bone marrow from lethal graft-versus-host disease. Transplant Proc. 1996 Dec;28(6):3114-6. PubMed PMID: 8962208. 15: Bruley-Rosset M, Churaqui E, Annat J, Dutartre P. LF 08-0299 protects murine recipients of minor antigen disparate donor marrow from lethal graft-versus-host disease. Ann N Y Acad Sci. 1995 Dec 29;770:373-5. PubMed PMID: 8597379. 16: Dutartre P, Annat J, Derrepas P. LF 08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model. Transplant Proc. 1995 Feb;27(1):440-2. PubMed PMID: 7879054. 17: Andoins C, de Fornel D, Annat J, Dutartre P. Both CD45RC+ and negative CD4+ suppressor cells are present in the rat cardiac allograft LF 08-0299-induced tolerance model. Transplant Proc. 1997 Feb-Mar;29(1-2):1282-4. PubMed PMID: 9123307. 18: Simpson D. New developments in the prophylaxis and treatment of graft versus host disease. Expert Opin Pharmacother. 2001 Jul;2(7):1109-17. Review. PubMed PMID: 11583062. 19: Lácha J, Rossmann P, Lodererová A, Havlíèková J, Vítko S. LF 08-0299 in the prophylaxis and treatment of chronic rejection in a rat aortic allograft model. Transpl Int. 2000;13 Suppl 1:S565-7. PubMed PMID: 11112075. 20: Andoins C, de Fornel D, Annat J, Dutartre P. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells. Transplantation. 1996 Dec 15;62(11):1543-9. PubMed PMID: 8970605.

View History

Treprostinil diolamine

Treprostinil diolamine

New Featured